Related Experiment Video
Updated: Jul 30, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
The optimal treatment strategy for chronic hepatitis C
S de Rave1, J M Vrolijk, S W Schalm
1Department of Gastroenterology and Hepatology, Erasmus Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. ravezeel@dds.nl
Medical Hypotheses
|June 1, 2005
Summary
For chronic hepatitis C, cyclic treatment may reduce overall treatment duration compared to a single prolonged course. This approach shows potential for maintaining effectiveness while optimizing patient management for hepatitis C virus (HCV).
Area of Science:
- Hepatology and Viral Gastroenterology
- Pharmacoeconomics and Treatment Optimization
Background:
- Chronic hepatitis C (HCV) presents a significant societal and economic burden.
- Current standard treatments like PEG-Interferon and Ribavirin are expensive, have side effects, and variable efficacy.
- Prolonged treatment durations (48-72 weeks) are trending for genotypes 1 and 4 to prevent relapse.
Purpose of the Study:
- To compare sustained response rates and mean treatment durations between one-time extended treatment and cyclic retreatment strategies for chronic hepatitis C.
- To evaluate the impact of treatment strategies on overall effectiveness and duration in a modeled patient population.
Main Methods:
- Development of a mathematical model simulating antiviral therapy for chronic hepatitis C.
- Incorporation of key parameters: non-response rates, on-treatment breakthrough, and post-treatment relapse rates.
- Comparative analysis of a single 12-month treatment versus repeated 6-month cyclic treatment regimens.
Main Results:
- Model calculations indicate that cyclic 6-month treatment reduces mean duration from 9.6 to 7.5 months compared to a single 12-month course.
- This reduction in treatment duration was achieved without compromising overall treatment effectiveness, even under unfavorable assumptions.
- The study suggests that treating relapses may yield response rates comparable to initial treatment attempts.
Conclusions:
- Cyclic retreatment strategies for chronic hepatitis C offer a potential to shorten overall treatment duration.
- This approach may provide a more efficient management strategy without sacrificing therapeutic efficacy.
- Current treatment guidelines for hepatitis C virus genotype 1 infections may warrant reconsideration based on these findings.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...